SONN Sonnet BioTherapeutics Holdings Inc

0.035 (1.24%)
After Hours
Last Updated: 16:00:01
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 16,773
Bid Price 2.85
Ask Price 2.97
News -
Day High 2.97


52 Week Range


Day Low 2.71
Company Name Stock Ticker Symbol Market Type
Sonnet BioTherapeutics Holdings Inc SONN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.035 1.24% 2.865 16:00:01
Open Price Low Price High Price Close Price Prev Close
2.79 2.71 2.97 2.865 2.83
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
274 16,773 $ 2.85 $ 47,846 - 2.665 - 66.00
Last Trade Time Type Quantity Stock Price Currency
16:00:00 28 $ 2.86 USD

Sonnet BioTherapeutics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.02M 1.75M - 350k -29.72M -16.98 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sonnet BioTherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SONN Message Board. Create One! See More Posts on SONN Message Board See More Message Board Posts

Historical SONN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.213.302.6652.9340,908-0.345-10.75%
1 Month4.314.802.6653.9678,318-1.45-33.53%
3 Months9.9010.562.6657.781,209,420-7.04-71.06%
6 Months7.8126.402.6659.982,786,590-4.95-63.32%
1 Year33.6666.002.66527.102,575,626-30.80-91.49%
3 Years770.001,051.822.665185.593,067,210-767.14-99.63%
5 Years1,915.764,989.602.665331.263,022,703-1,912.90-99.85%

Sonnet BioTherapeutics Description

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
Your Recent History
Sonnet Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now